Liming Shu

716 total citations
29 papers, 589 citations indexed

About

Liming Shu is a scholar working on Physiology, Epidemiology and Molecular Biology. According to data from OpenAlex, Liming Shu has authored 29 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 10 papers in Epidemiology and 8 papers in Molecular Biology. Recurrent topics in Liming Shu's work include Lysosomal Storage Disorders Research (11 papers), Acute Ischemic Stroke Management (6 papers) and Cerebrovascular and Carotid Artery Diseases (5 papers). Liming Shu is often cited by papers focused on Lysosomal Storage Disorders Research (11 papers), Acute Ischemic Stroke Management (6 papers) and Cerebrovascular and Carotid Artery Diseases (5 papers). Liming Shu collaborates with scholars based in United States, China and Netherlands. Liming Shu's co-authors include James A. Shayman, James L. Park, Subramaniam Pennathur, Lihsueh Lee, Johannes M. F. G. Aerts, Akira Abe, Bouwien E. Smid, Carla E. M. Hollak, Anuradha Vivekanandan‐Giri and Hao Wu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Bacteriology and Kidney International.

In The Last Decade

Liming Shu

28 papers receiving 577 citations

Peers

Liming Shu
Gerard De Jong Australia
R. Gatti Italy
Susan Goorden Netherlands
Vicki L. Nebes United States
Adriana Lombardo Italy
Antonietta Tarallo Italy
Jary S. Mayes United States
Fábio V. Fonseca United States
Khaja Basheeruddin United States
Pierre‐Alain Thiébaut France
Gerard De Jong Australia
Liming Shu
Citations per year, relative to Liming Shu Liming Shu (= 1×) peers Gerard De Jong

Countries citing papers authored by Liming Shu

Since Specialization
Citations

This map shows the geographic impact of Liming Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liming Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liming Shu more than expected).

Fields of papers citing papers by Liming Shu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liming Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liming Shu. The network helps show where Liming Shu may publish in the future.

Co-authorship network of co-authors of Liming Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Liming Shu. A scholar is included among the top collaborators of Liming Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liming Shu. Liming Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Wenjun, et al.. (2025). Real‐world prediction of early‐onset dementia by health record data: A multi‐center machine learning study. Alzheimer s & Dementia. 21(11). e70921–e70921.
2.
Shu, Liming, et al.. (2023). Evaluation of extent vs velocity of cortical venous filing in stroke outcome after endovascular thrombectomy. Neuroradiology. 65(7). 1155–1163. 1 indexed citations
3.
Shayman, James A., Vania Hinkovska‐Galcheva, & Liming Shu. (2023). Inhibitors of Glucosylceramide Synthase. Methods in molecular biology. 2613. 271–288. 5 indexed citations
4.
5.
6.
Shu, Liming, et al.. (2020). Application of spectral CT in the diagnosis of contrast encephalopathy following carotid artery stenting: a case report. BMC Neurology. 20(1). 413–413. 3 indexed citations
7.
Shu, Liming, et al.. (2020). Association of FLAIR vascular hyperintensity and acute MCA stroke outcome changes with the severity of leukoaraiosis. Neurological Sciences. 41(11). 3209–3218. 3 indexed citations
8.
Shu, Liming, et al.. (2019). The Association between FLAIR Vascular Hyperintensity and Stroke Outcome Varies with Time from Onset. American Journal of Neuroradiology. 40(8). 1317–1322. 15 indexed citations
9.
Desch, Karl C., et al.. (2018). α-galactosidase A deficiency promotes von Willebrand factor secretion in models of Fabry disease. Kidney International. 95(1). 149–159. 18 indexed citations
10.
Shu, Liming, et al.. (2018). Dissociation of globotriaosylceramide and impaired endothelial function in α-galactosidase-A deficient EA.hy926 cells. Molecular Genetics and Metabolism. 125(4). 338–344. 21 indexed citations
11.
Shu, Liming, Anuradha Vivekanandan‐Giri, Subramaniam Pennathur, et al.. (2014). Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease. Kidney International. 86(1). 58–66. 74 indexed citations
12.
Shu, Liming. (2012). Glycosphingolipid Mediated Caveolin-1 Oligomerization. PubMed. 1(S1). 1–6. 11 indexed citations
13.
Park, James L., Liming Shu, & James A. Shayman. (2009). Differential involvement of COX1 and COX2 in the vasculopathy associated with the α-galactosidase A-knockout mouse. American Journal of Physiology-Heart and Circulatory Physiology. 296(4). H1133–H1140. 15 indexed citations
14.
Shu, Liming, et al.. (2009). Decreased Nitric Oxide Bioavailability in a Mouse Model of Fabry Disease. Journal of the American Society of Nephrology. 20(9). 1975–1985. 51 indexed citations
15.
Park, James L., Steven E. Whitesall, Louis G. D’Alecy, Liming Shu, & James A. Shayman. (2008). VASCULAR DYSFUNCTION IN THE α‐GALACTOSIDASE A‐KNOCKOUT MOUSE IS AN ENDOTHELIAL CELL‐, PLASMA MEMBRANE‐BASED DEFECT. Clinical and Experimental Pharmacology and Physiology. 35(10). 1156–1163. 45 indexed citations
16.
Shu, Liming & James A. Shayman. (2007). Caveolin-associated Accumulation of Globotriaosylceramide in the Vascular Endothelium of α-Galactosidase A Null Mice. Journal of Biological Chemistry. 282(29). 20960–20967. 37 indexed citations
17.
Shu, Liming, Hedwig S. Murphy, Laura Cooling, & James A. Shayman. (2005). An In Vitro Model of Fabry Disease. Journal of the American Society of Nephrology. 16(9). 2636–2645. 29 indexed citations
18.
Shu, Liming & James A. Shayman. (2003). Src Kinase Mediates the Regulation of Phospholipase C-γ Activity by Glycosphingolipids. Journal of Biological Chemistry. 278(33). 31419–31425. 17 indexed citations
19.
Shayman, James A., Lihsueh Lee, Akira Abe, & Liming Shu. (2000). [38] Inhibitors of glucosylceramide synthase. Methods in enzymology on CD-ROM/Methods in enzymology. 311. 373–387. 48 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerard De Jong Breakdown of academic impact, for papers by R. Gatti Breakdown of academic impact, for papers by Susan Goorden Breakdown of academic impact, for papers by Vicki L. Nebes Breakdown of academic impact, for papers by Adriana Lombardo Breakdown of academic impact, for papers by Antonietta Tarallo Breakdown of academic impact, for papers by Jary S. Mayes Breakdown of academic impact, for papers by Fábio V. Fonseca Breakdown of academic impact, for papers by Khaja Basheeruddin Breakdown of academic impact, for papers by Pierre‐Alain Thiébaut
Rankless by CCL
2026